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Abstract
Autosomal recessive retinitis pigmentosa (arRP) is a clinically and genetically heterogeneous
retinal disease that causes blindness. Our purpose was to identify the causal gene, describe the
phenotype and delineate the mutation spectrum in a consanguineous Quebec arRP family. We
performed Arrayed Primer Extension (APEX) technology to exclude ~500 arRP mutations in ~20
genes. Homozygosity mapping [single nucleotide polymorphism (SNP) genotyping] identified 10
novel significant homozygous regions. We performed next generation sequencing and whole
exome capture. Sanger sequencing provided cosegregation. We screened another 150 retinitis
pigmentosa (RP) and 200 patients with Senior-Løken Syndrome (SLS). We identified a novel
missense mutation in WDR19, c.2129T>C which lead to a p.Leu710Ser. We found the same
mutation in a second Quebec arRP family. Interestingly, two of seven affected members of the
original family developed ‘sub-clinical’ renal cysts. We hypothesized that more severe WDR19
mutations may lead to severe ciliopathies and found seven WDR19 mutations in five SLS
families. We identified a new gene for both arRP and SLS. WDR19 is a ciliary protein associated
with the intraflagellar transport machinery. We are currently investigating the full extent of the
mutation spectrum. Our findings are crucial in expanding the understanding of childhood
blindness and identifying new genes.
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Retinitis pigmentosa (RP) is a well known inherited retinal dystrophy that leads to
progressive loss of vision, and eventually complete blindness due to photoreceptor cell
death. RP is restricted to the eye, specifically the retina and photoreceptors. Its prevalence is
estimated to be at 1/4000 (1–3). RP is caused by progressive loss of rods followed by the
loss of cones. Affected individuals start experiencing night blindness in the first two decades
of life. Peripheral visual field constriction leads to ‘tunnel vision’, progressive loss of visual
acuity (VA) leads to complete loss of all vision (4). On fundus exam, RP is classically
characterized by retinal atrophy, optic nerve head pallor, vascular narrowing and a variety of
peripheral retinal pigmentary deposits including bone spicules. RP can be restricted to the
eye (non-syndromic) or a retinal degeneration indistinguishable from RP can be associated
with a syndrome. The syndromic features can be very obvious or very subtle. Also, the
syndromic features can be present at the time of diagnosing the retinal degeneration, or they
may appear much later. Examples are Bardet–Biedl syndrome (BBS), Usher Syndrome
(USH) and Senior-Loken Syndrome (SLS). The mode of inheritance of RP may be
autosomal dominant [autosomal dominant retinitis pigmentosa (adRP); 5–25%], autosomal
recessive [autosomal recessive retinitis pigmentosa (arRP); 5–20%], rarely digenic,
mitochondrial or X-linked [Xlinked retinitis pigmentosa (xlRP); 5–15%] (5). There are
currently 36 genes implicated in arRP that only explain ~50% of the cases (RetNet),
illustrating that many mutations and new genes still need to be discovered. RPE65, which is
expressed in the retinal pigment epithelium (RPE), PDE6A and PDE6B, which are both
phosphodiesterase subunits in the phototransduction cascade, EYS and USH2A, are among
the most well-known or common genetic etiologies (5, 6).
Interestingly, several genes associated with RP (in patients without systemic disease) can
also be mutated in syndromic disorders such as BBS1 and USH2 (7, 8) and SLS which is an
autosomal recessive disease affecting primarily the kidney and retina, leading to
nephronophthisis (NPHP) and RP, respectively (9). Of particular interest in RP and these
syndromes is the emergence of a group of genes and proteins that function in and are
localized to the cilium, the so-called ciliary genes. In photoreceptor outer segments (OS,
which represent modified cilia), the stacked discs house the proteins for visual function with
several important RP ciliary gene products, e.g. RPGR, RPGRIP1, USH2A, CEP290, LCA5,
and TULP1.
We identified an atypical form of arRP in a French-Canadian family (Fig. 1) and excluded
mutations in all the known arRP genes. We hypothesized that this family carries mutations
in a novel RP specific gene and subsequently identified homozygous mutations in WDR19.
At the time of discovery (August 2011), there was no published article in the literature
linking this gene to any human disease and specifically to arRP. On re-evaluation of this
family, we discovered that several of the RP patients had sub-clinical renal cysts, which
prompted us to hypothesize that this gene may be mutated in RP patients with frank kidney
failure, a disorder coined SLS. We then performed mutation analysis in this gene in a cohort
of patients with RP in Quebec and a cohort with the syndromic form of RP, namely SLS and
identified more RP families and several SLS families with mutations. At this time, both
Bredrup et al. in their original article and Huber et al., in their review article, described the
involvement of WDR19, a ciliary gene, in a variety of ciliopathies including Sensenbrenner,
Jeune syndrome and isolated NPHP (10, 11). Similarly, Halbritter et al. reported the first
case of Caroli disease, which is a rare inherited disorder most commonly characterized by
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congenital cystic dilatation of the intrahepatic biliary ducts secondary to ectasia, caused by
mutations in WDR19. However, there is yet no study confirming clearly the involvement of
WDR19 in arRP as well as in SLS (12).
In the process of identifying a novel gene for RP and SLS, we also identified a novel
genotype–phenotype correlation in the arRP families. We illustrate that the combined use of
Arrayed Primer Extension (APEX) technology, homozygosity mapping by single nucleotide
polymorphism (SNP) genotyping and next generation sequencing (NGS), can rapidly and
reliably lead to new gene discovery.
Materials and methods
This study was approved by the Institutional Review Board (IRB) committee at the McGill
University Health Centre (MUHC), according to the tenets of Helsinki. Informed consents
were obtained from all patients. Ophthalmic examinations included best-corrected VA, slit-
lamp biomicroscopy, and funduscopy. Goldmann kinetic perimetry [Goldmann visual fields
(GVF)] was performed with four targets (IV/4e, III/4e, I/4e and I/3e) testing from non-
seeing retina to seeing retina. In vivo retinal imaging was performed in a subset of patients
by optical coherence tomography (OCT) (Heidelberg Engineering) and lipofuscin
metabolism was mapped using the fundus autofluorescence (FAF) module (Heidelberg
Engineering).
To identify the causal gene of the proband in family A, we used a novel four-step sequential
process. First, we excluded all known arRP mutations (700 mutations in 28 arRP genes,
version 2012) using APEX technology (Asper Ophthalmics). We then performed SNP
Homozygosity Mapping (Illumina Infinium HD 660K technology, San Diego, CA) followed
by whole exome capture (WEC, Agilent SureSelect V3, Santa Clara, CA) and NGS
(Illumina Hiseq, San Diego, CA) with a particular focus on the identified homozygous
regions. We finally confirmed the causal mutations using Sanger sequencing.
We then used a pipeline approach to exclude variants and we excluded the found mutation
from 500 normal controls. Cosegregation of the mutations was then performed in family A
and B by Sanger sequencing. We then screened ~150 RP patients (mostly from Quebec), 96
SLS patients, and 96 patients with more severe ciliopathy by applying a CEL1 endonuclease
based heteroduplex DNA cleavage procedure (13) followed by Sanger sequencing in an
attempt to find other families and to delineate the full mutation spectrum of the gene.
SNP genotyping
Whole-genome SNP genotyping (Affymetrix, Santa Clara, CA) was performed to identify
homozygous regions in family A (6). The DNA samples for SNP analysis were purified
(QIAamp DNA Mini Kit; Qiagen, Valencia, CA) and then genotyped. The SNP genotypes
were analyzed for homozygous regions (ExcludeAR sheet; Excel, Microsoft, Redmond,
WA). Chromosomal segments were accepted as having significant homozygous regions if
they contained ≥300 consecutive homozygous SNPs, as the likelihood that this would occur
by chance is less than 1:100 (14).
Whole exome capture and next generation sequencing
The pre-capture library was prepared following the manufacturer’s protocol (Illumina); 2 µg
of link-ligated DNA from the proband of family A was used for the capture reaction. Agilent
SureSelect V3 exome capture was performed according to the company’s standard protocol.
The amplified capture product was sequenced on Hiseq 2000 (Illumina). We removed
adaptor sequences and quality trimmed reads using the Fastx toolkit (http://
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hannonlab.cshl.edu/fastx_toolkit/) and then used a custom script to ensure that only read
pairs with both mates present were subsequently used. Reads were aligned to hg19 with
BWA 0.5.9, and indel realignment was carried out using the Genome Analysis Toolkit
(GATK) (15). Duplicate reads were then marked using Picard (http://
picard.sourceforge.net/) and excluded from downstream analyses. We assessed coverage of
consensus coding sequence (CCDS) bases using the GATK, which showed that >93% of
CCDS bases were covered by at least 10 reads. Single nucleotide variants (SNVs) and short
insertions and deletions were called using samtools pileup, and were then quality filtered to
require at least 20% of reads supporting the variant call. Variants were annotated using both
Annovar (16) and custom scripts to identify whether they affected protein coding sequence,
and whether they had previously been seen in dbSNP132, the 1000 genomes dataset
(November 2011), the NHLBI GO exomes, or in approximately 500 exomes previously
sequenced at our center.
Sanger sequencing and cosegregation
Direct polymerase chain reaction (PCR) and Sanger sequencing were used to validate the
mutations in the proband, their parents and siblings. Primers were designed using primer
design tool ‘Primer3’ (17). Each amplicon was 300–500 bp in length and was sequenced
directly with an ABI 3730 (Life Technologies Corporation, Carlsbad, CA) machine in both
forward and reverse directions. Each read was aligned to the reference sequence and the
base changes were identified with the SEQUENCHER software program.
Results
Genotype
Autosomal recessive retinitis pigmentosa (arRP)—In the consanguineous family A
(Fig. 1), after excluding known arRP mutations using APEX technology, we proceeded with
whole genome SNP genotyping and homozygosity mapping, (Table 1), and we ranked the
sizes of the homozygous regions in descending order. We found a total of 150Mb of
homozygosity most likely by descent in this Quebec family with a total of 11 significant
regions. The largest homozygous region was found on chromosome 3 (20.6Mb) while the
smallest one was found on chromosome 4 (7.2 Mb). Assuming consanguinity and recessive
mutations in the causal gene, it became evident from the non-overlap between known retinal
dystrophy loci and our identified homozygous regions that we were very likely dealing with
a new gene for arRP.
Without any potential lead candidate gene, we then used WEC/NGS with a particular focus
on the homozygous regions identified earlier in family A. A TMEM5 splice site mutation
was found on chromosome 1, but this change did not cosegregate in the family. We then
concentrated on a candidate missense mutation in AIFM3 on chromosome 22.
Unfortunately, this variant did not cosegregate either. Finally, we identified a missense
variant in WDR19 on chromosome 4, the smallest homozygous region. Using Sanger
sequencing we confirmed the mutation and found cosegregation in family A (Fig. 2). The
identified variant is a homozygous missense mutation c. 2129T>C, p. Leu710Ser in WDR19
(Fig. 2). The Leu710Ser mutation is predicted to be harmful according to POLYPHEN2, damaging
according to SIFT and evolutionarily highly conserved, as the Leucine is always present even
in Caenorhabditis elegans (Fig. 2). WDR19 is a ciliary gene that encodes the intraflagellar
transport 144 (IFT144) protein, and recently associated with a human disease during our
study (10). In order to investigate the full mutation spectrum of WDR19 in arRP and its
frequency, we assembled an arRP cohort from Quebec. After Sanger sequencing of an
unsettled cohort of 150 arRP from the Quebec province, we identified the same homozygous
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mutation again in a second Quebec arRP family B (Fig. 3). The mutation was not seen in
200 French-Canadian healthy control individuals.
We reassessed the phenotype of both families and discovered that two of seven family A
affected members had ‘sub-clinical’ renal cysts (Fig. 1). This unusual finding surprised us,
as arRP is not known to be associated with subclinical renal cysts. We performed renal
ultrasounds and renal function by urine biochemistry. Fig. 1 shows the large cysts in both
kidneys. Urine and blood biochemistry were normal, strongly suggesting normal renal
function. This led us to hypothesize that more severe mutations in WDR19 may be involved
in more severe and more complex phenotypes, involving other tissues such as kidney, brain
and others. First we hypothesized that our kidney cysts were a ‘forme fruste’ of NPHP and
turned our attention to SLS, which represents a ciliopathy with retinal and kidney
involvement.
Senior-Løken syndrome—Using the same genetic approach, we screened 96 patients
with SLS and found five families (7%) in which WDR19 was mutated (Table 2). Again, all
the mutations were predicted to be harmful. We found compound heterozygous and
heterozygous mutations (Table 2), and we identified both missense and frameshift mutations
in WDR19 (Fig. 2). They were confirmed by Sanger sequencing and found to cosegregate in
their respective families (Fig. 2). All mutations currently known are shown in Fig. 2.
Phenotype of the arRP families carrying the WDR19 missense mutation (p.Leu710Ser)
Family A—The proband (IV:4) in family A is a 50-year-old man from a consanguineous
French-Canadian family (Fig. 1). His acuities are hand motions only (HM) and his GVF are
abnormal with severe constriction down to 5°. Electroretinograms (ERGs) were
undetectable. His fundus examination showed 360° fine bone spicules in the periphery and
severely attenuated vessels occulus uterque (OU) (Fig. 1). Both optic discs showed slight
temporal pallor. There is a striking and significant macular atrophy (Fig. 1). On FAF this
maculopathy has a ‘bear claw’ appearance (Fig. 1). The in vivo retinal architecture by OCT
reveals considerable thinning of the fovea, a poorly delineated photoreceptor layer with
extensive loss of the inner segments (IS)/OS junctions as well as foveal debris, which are
likely attributed to the maculopathy described earlier (Fig. 1). When we reviewed the
phenotype of family A, we discovered that two of seven members reported having ‘kidney
problems’. A pelvic ultrasound scan (US) was performed and confirmed the presence of a
sub-clinical large exophytic cysts (Fig. 1). The urine analysis and blood biochemistry were
within normal ranges. The patient also presented with mild cognitive impairment.
Family B—The proband of family B (II:1) is a 43-year-old female also from a French-
Canadian family not known to be related to family A (Fig. 3). We found the same
homozygous p. Leu710Ser mutation in WDR19, suggestive of a founder mutation in
Quebec. Her VA was 20/100. The GVF show bilateral large central scotomas. On fundus
examination (Fig. 3), bone spicules, vessels attenuation and optic disc pallor can be
appreciated with a very similar atrophic foveal lesion in both eyes as was seen in family A.
Furthermore, the atypical ‘bear claw’ shaped maculopathy can be again clearly visualized on
FAF (Fig. 3). The OCT shows marked photoreceptor loss and IS/OS junction loss with
atrophy with mild foveal edema (Fig. 3). There were no renal cysts or any other renal
abnormalities in this proband.
Phenotype of the SLS families carrying the WDR19 mutations
All of the reported five patients exhibited retinal dystrophy and NPHP. Additionally, most
showed specific phenotypic characteristics involving different organ systems. These
included growth retardation and cognitive impairment, hip dysplasia and scoliosis,
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ventricular septum defect as well as gestational polyhydramnios and Jeune asphyxiating
thoracic dystrophy (Table 2).
Discussion
Cilia and flagella are subcellular ‘antenna-like’ organelles that project from the cell surface.
They are highly conserved in evolution as they play important roles in cell motility, sensory
stimuli reception, and early developmental processes. In humans, cilia are almost
ubiquitously present on many different cell types. Photoreceptor OS in the retina represent
modified cilia. Defects in their structure or function lead to a wide range of developmental
problems and diseases, including RP and SLS (18–21). The assembly and further structural
and functional maintenance of cilia and flagella are dependent on the process of IFT, which
brings the proteins to the place of work (in the photoreceptor this is the OS). The
phylogenetically highly conserved IFT represents a bidirectional machinery required for
cilia development, maintenance and signaling. The anterograde (from the base to the tip) and
retrograde movement (from the tip back to the base) requires three components; motor
proteins, IFT particles and the cargo (proteins destined for the OS). For the anterograde
movement, kinesin motors and the IFT-B particles are used, while for retrograde movement,
dynein motors and IFT-A particles are utilized. Retrograde movement not only recycles the
proteins but also participates in sonic hedgehog signaling (22). How the IFT A and B
particles are assembled at the ciliary base, how the correct cargo is chosen and bound to the
IFT particles and moved to the ciliary tip, exchanged and then released at the base on the
other side of the cilium is an area of intense research and current interest.
WDR19, also known as DYF-2 (in C. elegans) is expressed in the retina, particularly in
photoreceptors but also many other tissues and encodes the IFT144 protein particle. IFT144
is an IFT-A component, involved in retrograde movement of cargo in the cilium. IFT-A
components (genes) have been found to be predominantly mutated in skeletal diseases.
WDR19 encodes a large protein with 1342 amino acids, 37 exons and three different types of
domains in the IFT144 protein. There are six WD40 domains, which are short structural
motifs of 40 amino acids ending in the tryptophan–aspartic-acid dipeptide (W–D), two
transmembrane domains (TM), and six tetratricopeptide (TPR) domains. The common
function of all WD40 containing proteins is the coordination of the assembly of multi-
protein complexes. TPR domains mediate protein–protein interactions and multiprotein
complexes.
When we started this genetic study, WDR19 mutations were not known to be associated with
human disease. During our study, a link between WDR19 and human disease was found by
Bredrup et al. (10). Because of its crucial ciliary function and conservation between man and
C. elegans (22, 23), we argued that it was a prime candidate gene for arRP. We then
identified a novel homozygous missense mutation (p. Leu710Ser) in WDR19 in two
unrelated French-Canadian RP families. This illustrates that WDR19 is crucial to
photoreceptor survival or maintenance, and suggests that p.Leu710Ser represents a founder
mutation in the Quebec population. Our further studies suggest that WDR19 mutations are a
rare cause of arRP. Striking is the unusual ‘bear track’ maculopathy in both families (Figs 1
and 3), suggesting a novel genotype–phenotype correlation. Finding sub-clinical renal cysts
in some of the RP patients in one of the families (Fig. 1) are highly unusual, suggesting to us
to investigate more severe ciliopathies. Our hypothesis that more severe WDR19 mutations
lead to more severe systemic disease including SLS was confirmed when we identified
frameshift mutations in WDR19 in patients with SLS.
To our knowledge, this is the first study reporting the direct involvement of WDR19 in arRP
as well as in SLS. In fact, both diseases are known in part to be based on ciliary pathologies.
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In arRP, the photoreceptors, which are the structures reported to be damaged, are derived
from a ciliary ancestor. SLS is a syndrome of NPHP associated with RP. NPHP is
characterized by anemia, polyuria, polydipsia, isosthenuria and cysts mainly at the
corticomedullary border of the kidney. The latter is a form of ciliopathy that develops due to
an excess vacuole loss of normal tissue (24).
Once we confirmed that WDR19 mutations are a rare cause of RP and SLS, we hypothesized
further that more severe human phenotypic manifestations could also result from this
ubiquitously expressed gene. During our study, Bredrup et al. answered our suspicion in
their study identifying WDR19 mutations in Sensenbrenner, Jeune syndrome and isolated
NPHP (10). Remarkably, their group also identified the p.Leu710Ser mutation in several
different disease entities/ ciliopathies. They reported compound heterozygous mutations in
Sensenbrenner syndrome (p.Leu710Ser and p.Arg1103X), combining the Leu710Ser
missense mutation of our study with a nonsense mutation that likely leads to pre-mature
WDR19 protein truncation. Sensenbrenner is also known as cranioectodermal dysplasia-1,
an autosomal recessive disorder with sagittal craniosynostosis (early closure of the scalp and
orbital sutures), and facial, ectodermal and skeletal anomalies. The most prominent
phenotypic features of Sensenbrenner are remarkably bony defects, with dysmorphic facies,
short limbs, abnormal teeth, skin laxity and hernias. Sensenbrenner patients can have normal
retinas and normal kidneys or they can develop RP or nephronophtisis.
They also found the same homozygous missense mutation in Jeune syndrome
(p.Leu710Ser), a rare autosomal recessive potentially lethal congenital dwarfism, also
known as familial asphyxiating thoracic dystrophy. The phenotype is again dominated by
the skeletal abnormalities, and death is often due to narrow thorax and respiratory failure.
Kidney disease may be seen. Finally they found compound heterozygous mutations in
isolated NPHP (p. Val345Gly and p. Tyr1023X), again combining a missense and nonsense
mutation (10).
Among the seven patients reported in this study, three had novel mutations in WDR19
(Table 2). In particular, p.Val68Asp resulted in isolated case of retinal dystrophy and NPHP
while p.Ala30Pro and p.Gly109Glu lead to severer phenotypes involving skeletal and
cardiac anomalies as well as gestational complications and cognitive impairment,
respectively. The remaining four patients had their mutations previously reported by various
groups (10–12). Besides their different severity and syndromic manifestations, all the
mutations share a common pathophysiology related to a dysfunctional ciliopathy in a
specific organ system. What dictates the involvement of a specific organ system vs another
could be related to the mutation itself as well as the presence of modifying genes/mutations.
Functional studies need to be undertaken to fully understand this phenomenon.
It is of great scientific interest that the p. Leu710Ser mutations in our two arRP families are
the same as those identified by Bredrup et al. in families with Sensenbrenner and Jeune
syndromes (10). Aside from the important clinical fact that this mutation can easily be tested
as the first genetic test in RP patients with cysts and in new children diagnosed with the
much more severe and deadly Jeune and Sensenbrenner syndromes, is the suggestion of
modifier effects. These data of a phenotype severity spectrum (RP, RP with cysts, isolated
nephronophtisis, SLS, Sensenbrenner, and lethal Jeune syndrome) associated with the same
missense mutation (p. Leu710Ser) strongly suggest the presence of modifying genes/
mutations, additional ciliary mutations, genetic load or micro-environment variations (25–
28). For instance, a change in the penetrance of retinal degeneration among ciliopathies were
associated with mutations in RPGRIP1L. Similarly, mutations in AHI1 were reported to
cause retinal phenotypic variations in NPHP16 (25, 29, 30). In fact, Hildebrandt et al.
suggested the possible presence of a modifier gene in patients with NPHP-associated
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ciliopathies (22). Additionally, in their studies in Dync2h1 knockout mice, Ocbina et al.
showed the presence of a ‘rescue route’ based on mutations in Ift172 and Ift122 (31). Such
mutations could serve as modifier effects in gene encoding for IFT-associated proteins and
thus contribute to the phenotypic severity spectrum. The p. Leu710Ser mutation is not found
in a WDR19 protein domain but the Leucine is conserved all the way down the evolutionary
ladder to the nematode C. elegans (Fig. 2). However, its effects are severe, as Bredrup et al.
found that in fibroblast cultures of Sensenbrenner patients, there was no IFT144 protein in
the cilia, thus indicating a complete loss of function of IFT144 due to the p. Leu710Ser
mutation (10). This missense mutation may therefore be acting as a null allele.
Conclusion
In conclusion, we show that WDR19 mutations are a rare cause of arRP and SLS. Our results
suggest that there is a large phenotypic disease and severity spectrum associated with
WDR19 mutations. These manifestations range from isolated cases of arRP, arRP with cysts,
isolated NPHP to syndromal manifestations seen in SLS and even very severe
manifestations such as those in Sensenbrenner syndrome and the lethal Jeune syndrome. In
the process of re-evaluating and delineating the WDR19 mutation phenotype in arRP, we
discovered a novel genotype–phenotype correlation, a very distinct ‘bear claw maculopathy’
(Figs 1 and 3). It will be interesting to investigate the maculopathies referred to in SLS
patients and in those noted in the Bredrup et al. study. It is important to re-evaluate patients
after the genotype has been determined, and to search for subtle subclinical phenotypes.
Syndromic disease genes may also cause isolated diseases without the systemic
manifestations.
Acknowledgments
We thank all the patients and their families for their enthusiastic support. We would like to disclose the financial
support of the Foundation Fighting Blindness of Canada, FRSQ, Reseau Vision, NIH and CIHR (to R.K.K.). This
research was supported by grants from the National Institutes of Health to F. H. (DK068306) and to E. A.O
(DK090917).
References
1. Ammann F, Klein D, Franceschetti A. Genetic and epidemiological investigations on pigmentary
degeneration of the retina and allied disorders in Switzerland. J Neurol Sci. 1965; 2:183–196.
[PubMed: 5878602]
2. Boughman JA, Conneally PM, Nance WE. Population genetic studies of retinitis pigmentosa. Am J
Hum Genet. 1980; 32:223–235. [PubMed: 7386458]
3. Jay M. On the heredity of retinitis pigmentosa. Br J Ophthalmol. 1982; 66:405–416. [PubMed:
7093178]
4. Rivolta C, Sharon D, DeAngelis MM, Dryja TP. Retinitis pigmentosa and allied diseases: numerous
diseases, genes, and inheritance patterns. Hum Mol Genet. 2002; 11:1219–1227. [PubMed:
12015282]
5. Pagon, RA.; Daiger, SP. [Accessed on April 12, 2013] NBK1417PMID: 20301590, from http://
www.ncbi.nlm.nih.gov/pubmed/20301590
6. den Hollander AI, Black A, Bennett J, Cremers FP. Lighting a candle in the dark: advances in
genetics and gene therapy of recessive retinal dystrophies. J Clin Invest. 2010; 120(9):3042–3053.
[PubMed: 20811160]
7. [Accessed on April 12, 2013] From http://www.ncbi.nlm.nih.gov/books/NBK1363/
8. [Accessed on April 12, 2013] From http://www.ncbi.nlm.nih.gov/books/NBK1417/
9. From http://omim.org/entry/266900.
Coussa et al. Page 8
Clin Genet. Author manuscript; available in PMC 2014 February 01.
H
H
M
I Author M
anuscript
H
H
M
I Author M
anuscript
H
H
M
I Author M
anuscript
10. Bredrup C, Saunier S, Oud MM, et al. Ciliopathies with skeletal anomalies and renal insufficiency
due to mutations in the IFT-A gene WDR19. Am J Hum Genet. 2011; 89:634–643. [PubMed:
22019273]
11. Huber C, Cormier-Daire V. Ciliary disorder of the skeleton. Am J Med Genet C Semin Med Genet.
2012; 160C(3):165–174. [PubMed: 22791528]
12. Halbritter, J.; Porath, JD.; Diaz, KA., et al. Identification of 99 novel mutations in a worldwide
cohort of 1,056 patients with a nephronophthisis-related ciliopathy. Hum Genet. 2013. http://
www.ncbi.nlm.nih.gov/pubmed/23559409
13. Otto EA, Helou J, Allen SJ, et al. Mutation analysis in nephronophthisis using a combined
approach of homozygosity mapping, CEL I endonuclease cleavage, and direct sequencing. Hum
Mutat. 2008; 29(3):418–426. [PubMed: 18076122]
14. Woods CG, Valente EM, Bond J, Roberts E. A new method for autozygosity mapping using single
nucleotide polymorphisms (SNPs) and EXCLUDEAR. J Med Genet. 2004; 41(8):e101. [PubMed:
15286161]
15. McKenna A, Hanna M, Banks E, et al. The genome analysis toolkit: a MapReduce framework for
analyzing next-generation DNA sequencing data. Genome Res. 2010; 20(9):1297–1303. [PubMed:
20644199]
16. Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-
throughput sequencing data. Nucleic Acids Res. 2010; 38(16):e164. [PubMed: 20601685]
17. From http://biotools.umassmed.edu/bioapps/primer3_www.cgi.
18. Pazour GJ, Rosenbaum JL. Intraflagellar transport and cilia-dependent diseases. Trends Cell Biol.
2002; 12:551–555. [PubMed: 12495842]
19. Rosenbaum JL, Witman GB. Intraflagellar transport. Nat Rev Mol Cell Biol. 2002; 3:813–825.
[PubMed: 12415299]
20. Scholey JM. Intraflagellar transport. Annu Rev Cell Dev Biol. 2003; 19:423–443. [PubMed:
14570576]
21. Afzelius BA. Cilia-related diseases. Pathol. 2004; 204:470–477.
22. Blacque OE, Perens EA, Boroevich KA, et al. Functional genomics of the cilium, a sensory
organelle. Curr Biol. 2005; 15(10):935–941. [PubMed: 15916950]
23. Murayama T, Toh Y, Ohshima Y, Koga M. The dyf-3 gene encodes a novel protein required for
sensory cilium formation in Caenorhabditis elegans. J Mol Biol. 2005; 346:677–687. [PubMed:
15713455]
24. Hildebrandt F, Zhou W. Nephronophthisis-associated ciliopathies. J Am Soc Nephrol. 2007;
18:1855–1871. [PubMed: 17513324]
25. Davis EE, Zhang Q, Liu Q, et al. TTC21B contributes both causal and modifying alleles across the
ciliopathy spectrum. Nat Genet. 2011; 43:189–196. [PubMed: 21258341]
26. Thiel C, Kessler K, Giessl A, et al. NEK1 mutations cause short-rib polydactyly syndrome type
majewski. Am J Hum Genet. 2011; 88:106–114. [PubMed: 21211617]
27. Badano JL, Leitch CC, Ansley SJ, et al. Dissection of epistasis in oligogenic Bardet-Biedl
syndrome. Nature. 2006; 439:326–330. [PubMed: 16327777]
28. Hoefele J, Wolf MT, O’Toole JF, et al. Evidence of oligogenic inheritance in nephronophthisis. J
Am Soc Nephrol. 2007; 18:2789–2795. [PubMed: 17855640]
29. Khanna H, Davis EE, Murga-Zamalloa CA, et al. A common allele in RPGRIP1L is a modifier of
retinal degeneration in ciliopathies. Nat Genet. 2009; 41:739–745. [PubMed: 19430481]
30. Louie CM, Caridi G, Lopes VS, et al. AHI1 is required for photoreceptor outer segment
development and is a modifier for retinal degeneration in nephronophthisis. Nat Genet. 2010;
42:175–180. [PubMed: 20081859]
31. Ocbina PJ, Eggenschwiler JT, Moskowitz I, Anderson KV. Complex interactions between genes
controlling trafficking in primary cilia. Nat Genet. 2011; 43:547–553. [PubMed: 21552265]
Coussa et al. Page 9
Clin Genet. Author manuscript; available in PMC 2014 February 01.
H
H
M
I Author M
anuscript
H
H
M
I Author M
anuscript
H
H
M
I Author M
anuscript
Fig. 1.
(a) Family A pedigree. (b) Retinal photo showing an atrophic maculopathy and severe
narrowing of the blood vessels and temporal pallor of the optic nerve head. (c) Fundus
autofluorescence showing the ‘bear claw’ maculopathy and hypo-fluorescence in the fovea.
(d) Optical coherence tomography of the macula showing extensive loss of the inner
segment/outer segment junctions and photoreceptors, with inner retinal changes, retinal
thinning and foveal debris. (e) Renal ultrasound showing the renal cyst of the probands of
family A.
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Fig. 2.
(a) Gene and protein structure of WDR19 and IFT144, showing the protein domains and the
positions of all the mutations found in this study and in Bredrup et al. showing that most
mutations are in protein domains except the p. L710S mutation. (b) Conservation of the
Leucine at position 710 in IFT144 (WDR19) among species. (c) Sanger sequencing results
of the WDR19 mutations in Family A. (d) Sanger sequencing results of the WDR19
mutations in Senior-Loken syndrome patients.
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Fig. 3.
(a) Family B pedigree. (b) Retinal photo showing an atrophic maculopathy and severe
narrowing of the blood vessels and temporal pallor of the optic nerve head. (c) Peripheral
bone spicules, extensive. (d) Fundus autofluorescence showing the ‘bear claw’ maculopathy
and the hypofluorescence in the fovea. (e) Optical coherence tomography of the macula
showing extensive loss of the inner segment/outer segment junctions and photoreceptors,
with inner retinal changes, retinal thinning and foveal debris.
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Table 1
Result of homozygosity mapping in family A: proband (IV:4)
CHR Size (millions BP) NSNP Rank
3 20.6 4307 1
18 19.8 5165 2
8 19.6 4265 3
1 14.6 3716 4
19 14.2 3631 5
20 12.5 4415 6
15 12.3 3281 7
22 11.7 3270 8
9 10.3 3225 9
4 7.3 1589 10
4 7.2 2126 11
CHR, chromosome; NSNP, number of single-nucleotide polymorphism.
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